FDA-Approved Hypnotic Medications Increase Risk For Suicidal Ideation

Healio (9/15, Oldt) reports, “A literature review” published online Sept. 9 in the American Psychiatric Association’s American Journal of Psychiatry suggested that Food and Drug Administration-approved “hypnotic medications were associated with increased risk for suicidal ideation.” In particular, the study authors “expressed concern regarding benzodiazepine receptor agonist hypnotics, which can cause parasomnias and may lead to suicidal ideation or behavior in individuals not known to be suicidal.”

Related Links:

— “Hypnotics may increase risk for suicidal ideation, suicide,” McCall WV, et al., Healio, September 15, 2016.

Posted in In The News.